StockData
Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc. (ATOS) stock

ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.90−0.03 (-1.55%)

Close on Nov 17, 2026Market cap $18.96MP/E –Yield –

Atossa Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Atossa Therapeutics's price to book ratio was 0.8× on Nov 11, 2026, against 2.0× a year earlier. Over the last 5 years it ranged from 0.5× to 2.5×, with a median of 1.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.8×−0.8
2025Dec 31, 20251.5×−0.1
2024Dec 31, 20241.6×+0.5
2023Dec 29, 20231.1×+0.6
2022Dec 30, 20220.5×−0.9
2021Dec 31, 20211.4×+0.4
2020Dec 31, 20201.0×+0.1
2019Dec 31, 20191.0×+0.4
2018Dec 31, 20180.5×−0.9
2017Dec 29, 20171.4×+0.4
2016Dec 30, 20161.0×−0.1
2015Dec 31, 20151.1×−1.2
2014Dec 31, 20142.3×−1.2
2013Dec 31, 20133.5×−10.4
2012Dec 31, 201213.9×–

More Atossa Therapeutics figures

See a number that looks wrong?